Loqoa Tape (esflurbiprofen transdermal) / Taisho - LARVOL DELTA

Safety and Efficacy of SFPP in Knee Osteoarthritis (clinicaltrials.gov) - P3; N=313; Completed; Sponsor: Taisho Pharmaceutical Co., Ltd.; Recruiting ➔ Completed; Trial completion date: May 2021 ➔ Jan 2021

Clinical • Trial completion • Trial completion date • Immunology • Musculoskeletal Pain • Osteoarthritis • Pain • Rheumatology

LncRNAs expression in adriamycin-induced rats reveals the potential role of LncRNAs contributing to chronic glomerulonephritis pathogenesis. (PubMed, Gene) - "The ten LncRNAs were differentially expressed and might play important roles in the development of CGN. Key genes, such as Il6, Ptprc, TOP2a, Fos, Myc, etc., may be crucial biomarkers for CGN."

Biomarker • Journal